How to Test Human-Specific Combination Immunotherapies In Vivo
Descrição
Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.
Antibodies, Free Full-Text
Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity
Cancer vaccines: the next immunotherapy frontier
Frontiers Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
The Progress of Precision Medicine in Immuno-Oncology
Modeling human tumor-immune environments in vivo for the preclinical assessment of immunotherapies
IJMS, Free Full-Text
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Frontiers Advances in Human Dendritic Cell-Based Immunotherapy Against Gastrointestinal Cancer
Advancing Precision Medicine: In Vitro Potency Assays for Evaluating the Function of anti-PD-1 Checkpoint Inhibitors
Repurposing Ponatinib as a PD-L1 Inhibitor Revealed by Drug Repurposing Screening and Validation by In Vitro and In Vivo Experiments
de
por adulto (o preço varia de acordo com o tamanho do grupo)
